Citation Impact
Citing Papers
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein
2005 StandoutNobel
Roles of tau protein in health and disease
2017
Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study
2012 Standout
Ferroptosis: past, present and future
2020 Standout
Cellular Inclusion Bodies of Mutant Huntingtin Exon 1 Obscure Small Fibrillar Aggregate Species
2012 StandoutNobel
Does plastic waste kill mangroves? A field experiment to assess the impact of macro plastics on mangrove growth, stress response and survival
2020 Standout
Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration
2013
Magnesium in the Central Nervous System
2011
Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis
2014
Parkinson disease
2017 Standout
Recent advances in our understanding of neurodegeneration
2009
A homologue of the Parkinson’s disease-associated protein LRRK2 undergoes a monomer-dimer transition during GTP turnover
2017
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
2007 Standout
Synergistic Interactions between Aβ, Tau, and α-Synuclein: Acceleration of Neuropathology and Cognitive Decline
2010
Pathological Proteins in Parkinson's Disease: Focus on the Proteasome
2004
Brain Ferritin Iron as a Risk Factor for Age at Onset in Neurodegenerative Diseases
2004
Parkinson's disease
2021 Standout
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
2007 Standout
Dose- and time-dependent α-synuclein aggregation induced by ferric iron in SK-N-SH cells
2010
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Pathological roles of MAPK signaling pathways in human diseases
2010 Standout
Biological and Clinical Implications of Comorbidities in Parkinson’s Disease
2017
Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease
2010
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
2015 Standout
Neurochemistry and the non-motor aspects of PD
2011
Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease
2006
Carbonic anhydrase activators: The first X-ray crystallographic study of an adduct of isoform I
2006
Microglial cell origin and phenotypes in health and disease
2011 Standout
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Lipid peroxidation and neurodegenerative disease
2011
Redox Regulation of Cellular Stress Response in Aging and Neurodegenerative Disorders: Role of Vitagenes
2006
Overdependence on degraded gist memory in Alzheimer's disease.
2006 Standout
Anti-inflammatory effects of pioglitazone on iron-induced oxidative injury in the nigrostriatal dopaminergic system
2010
Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage
2007
Parkinson's disease
2009 Standout
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Carbonic anhydrase activators: l-Adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV
2006
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Screening of innate immune receptors in neurodegenerative diseases: A similar pattern
2007
Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: Relevance to Alzheimer's disease
2006
Substitution p.A350V in Na+/Mg2+ Exchanger SLC41A1, Potentially Associated with Parkinson's Disease, Is a Gain-of-Function Mutation
2013
Aggregated and Monomeric α-Synuclein Bind to the S6′ Proteasomal Protein and Inhibit Proteasomal Function
2003
Redox proteomic identification of 4-Hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease
2008
A Progressive Mouse Model of Parkinson's Disease: The Thy1-aSyn (“Line 61”) Mice
2012
α-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia
2006
Autophagy in Human Health and Disease
2013 Standout
Immunological features of α‐synuclein in Parkinson's disease
2008
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
2008 Standout
Caffeine and risk of Parkinson's disease in a large cohort of men and women
2012
Alzheimer's disease
2016 Standout
α-Synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: Lessons from viral transduction of knockout mice
2008
Parkinson's disease, insulin resistance and novel agents of neuroprotection
2012
Parkinson's Disease α-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death
2006
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
The ubiquitin system: pathogenesis of human diseases and drug targeting
2004 StandoutNobel
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
2006 StandoutNature
Calcium(II) selectively induces α‐synuclein annular oligomers via interaction with the C‐terminal domain
2004
Phosphorylation at Ser-129 but Not the Phosphomimics S129E/D Inhibits the Fibrillation of α-Synuclein
2008
Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies
2009
Non-motor features of Parkinson disease
2017 Standout
The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review
2018
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Adenosine receptors as drug targets — what are the challenges?
2013
Proteomic identification of nitrated brain proteins in early Alzheimer’s disease inferior parietal lobule
2008
Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities
2012 StandoutNobel
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Role of Iron in Neurodegenerative Disorders
2006
Magnesium deficiency over generations in rats with special references to the pathogenesis of the parkinsonism–dementia complex and amyotrophic lateral sclerosis of Guam
2006
Cortical α-synuclein load is associated with amyloid-β plaque burden in a subset of Parkinson’s disease patients
2008
Brain ferritin iron may influence age- and gender-related risks of neurodegeneration
2006
Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study
2007
Tau imaging: early progress and future directions
2014
Redox imbalance
2004
A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides
2008 StandoutNobel
Parkinson's Disease
2003 Standout
Mitochondrial Dysfunction in Genetic Animal Models of Parkinson's Disease
2011
Ligand-Gated Ion Channels: New Insights into Neurological Disorders and Ligand Recognition
2012
Development of allosteric modulators of GPCRs for treatment of CNS disorders
2013
Magnesium in Man: Implications for Health and Disease
2014 Standout
The Concept of Prodromal Parkinson’s Disease
2015
Genetic mouse models of Parkinson’s disease
2010
Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
2015
Development of an Ion Mobility Quadrupole Time of Flight Mass Spectrometer
2008 StandoutNobel
Huntington's disease: from pathology and genetics to potential therapies
2008
KEGG: integrating viruses and cellular organisms
2020 Standout
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degenerationin vivo
2005
Endoplasmic reticulum-associated SKN-1A/Nrf1 mediates a cytoplasmic unfolded protein response and promotes longevity
2019 StandoutNobel
Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade
2018
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
The Parkinson’s disease-linked protein TMEM230 is required for Rab8a-mediated secretory vesicle trafficking and retromer trafficking
2016
Proteasome dysfunction triggers activation of SKN-1A/Nrf1 by the aspartic protease DDI-1
2016 StandoutNobel
Protein Expression in a Drosophila Model of Parkinson's Disease
2006
In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease
2020
CSF or Serum Neurofilament Light Added to α‐Synuclein Panel Discriminates Parkinson's From Controls
2019
Basic science breaks through: New therapeutic advances in Parkinson's disease
2015
Nigral Iron Elevation Is an Invariable Feature of Parkinson’s Disease and Is a Sufficient Cause of Neurodegeneration
2014
Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis
2009
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
New ghrelin agonist, HM 01 alleviates constipation and L‐dopa‐delayed gastric emptying in 6‐hydroxydopamine rat model of P arkinson's disease
2014
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Alpha‐synuclein and its disease‐causing mutants induce ICAM‐1 and IL‐6 in human astrocytes and astrocytoma cells
2006
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
2019 Standout
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
Physiology of Microglia
2011 Standout
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of Mark Frasier being referenced
α-synuclein Imaging: A Critical Need for Parkinson's Disease Research
2013
Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s disease
2017
Mitochondrial associated metabolic proteins are selectively oxidized in A30P α-synuclein transgenic mice—a model of familial Parkinson's disease
2005
Priorities in Parkinson's disease research
2011
A user's guide for α‐synuclein biomarker studies in biological fluids: Perianalytical considerations
2017
Following the leader: fibrillization of ?-synuclein and tau
2004
Tau phosphorylation increases in symptomatic mice overexpressing A30P α-synuclein
2004
Magnesium Inhibits Spontaneous and Iron-induced Aggregation of α-Synuclein
2002
Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral Organs
2013
Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features
2017